Fig. 2From: Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters a, b Concentration time curves of one study day of the 50Â mg talinolol study phase (a) and the 2.5Â mg talinolol study phase (b). c Correlation of the AUC7h after the administration of 50Â mg and 2.5Â mg talinolol. Shown are all 72 individuals who received both dosages. AUC 7h area under the curve in the first 7Â hours after applicationBack to article page